HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs,...